Company Description

Daxor Corporation engages in medical instrumentation and biotechnology operations.

It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.

The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973.

Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

Daxor Corporation

Country	United States
Founded	1970
Industry	Medical Instruments & Supplies
Sector	Healthcare
Employees	45
CEO	Michael Feldschuh

Contact Details

Address: 109 Meco Lane Oak Ridge, Tennessee 37830 United States
Phone	865 425 0555
Website	daxor.com

Stock Details

Ticker Symbol	DXR
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0000027367
CUSIP Number	239467103
ISIN Number	US2394671034
Employer ID	13-2682108

Key Executives

Name	Position
Michael Richard Feldschuh	Chairman, President and Chief Executive Officer
Jonathan Adam Feldschuh	Chief Scientific Officer and Director
Dr. John Lynn Jefferies FACC, M.B.A., M.D., M.P.H.	Chief Medical Officer
Linda Cooper	Vice President of Development and Operations
Kathryn A. Kornafel	Senior Vice President of Marketing and Commercial Development

Latest SEC Filings

Date	Type	Title
Sep 4, 2026	40-8F-2/A	Filing
Aug 31, 2026	NPORT-P	Monthly Portfolio Investments Report on Form N-PORT (Public)
Aug 31, 2026	N-CSR	Filing
Aug 31, 2026	N-PX	Annual Report of proxy voting record of management investment companies
Jun 24, 2026	8-K	Current Report
Jun 17, 2026	40-8F-2/A	Filing
Jun 3, 2026	DEF 14A	Other definitive proxy statements
Jun 2, 2026	NT NPORT-P	Filing
May 21, 2026	40-8F-2/A	Filing
May 11, 2026	40-17F2	Filing

View All SEC Filings